MedX Health Corp
MDX.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 127.80K | 99.30K | 98.20K | 64.00K | 77.40K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 127.80K | 99.30K | 98.20K | 64.00K | 77.40K |
| Cost of Revenue | 83.00K | 211.90K | 71.20K | 51.20K | 44.20K |
| Gross Profit | 44.80K | -112.60K | 27.00K | 12.70K | 33.20K |
| SG&A Expenses | 601.10K | 705.50K | 574.00K | 595.40K | 783.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 785.80K | 1.01M | 736.20K | 737.50K | 914.20K |
| Operating Income | -658.00K | -907.70K | -638.00K | -673.50K | -836.80K |
| Income Before Tax | -879.50K | -1.49M | -931.90K | -951.00K | -1.11M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -879.50K | -1.49M | -931.90K | -951.00K | -1.11M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -879.50K | -1.49M | -931.90K | -951.00K | -1.11M |
| EBIT | -658.00K | -907.70K | -638.00K | -673.50K | -836.80K |
| EBITDA | -657.50K | -1.78M | -628.60K | -665.20K | -828.80K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 327.93M | 320.15M | 301.79M | 290.79M | 272.31M |
| Average Diluted Shares Outstanding | 327.93M | 320.15M | 301.79M | 290.79M | 272.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |